BillionToOne is a molecular diagnostics company that develops tests using proprietary technology to detect and quantify DNA at extremely low levels. The company offers prenatal screening through UNITY Complete, which evaluates fetal chromosomal and genetic risks; Northstar Select, a tumor analysis test that identifies specific mutations; and Northstar Response, a cancer monitoring assay that measures disease burden without tissue sampling. Based in Menlo Park, California, the company was founded in 2016.

entry readiness 12 · NOT READY · exit proximity 0

Value area 88.15–117.12 · 27% of 120d volume overhead · moderate overhead